Paradigm Biopharmaceuticals Ltd
ASX:PAR

Watchlist Manager
Paradigm Biopharmaceuticals Ltd Logo
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Watchlist
Price: 0.32 AUD 6.67% Market Closed
Market Cap: 137.1m AUD

Intrinsic Value

The intrinsic value of one PAR stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.32 AUD, Paradigm Biopharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PAR Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Paradigm Biopharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

PAR looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if PAR is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PAR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PAR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Paradigm Biopharmaceuticals Ltd.

Explain Valuation
Compare PAR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PAR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Paradigm Biopharmaceuticals Ltd

Current Assets 24.1m
Cash & Short-Term Investments 16.8m
Receivables 6.4m
Other Current Assets 935.1k
Non-Current Assets 444.5k
PP&E 29.8k
Intangibles 414.7k
Current Liabilities 3.2m
Accounts Payable 2.7m
Accrued Liabilities 493.1k
Other Current Liabilities 5.4k
Non-Current Liabilities 154.1k
Other Non-Current Liabilities 154.1k
Efficiency

Free Cash Flow Analysis
Paradigm Biopharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Paradigm Biopharmaceuticals Ltd

Revenue
7.1m AUD
Cost of Revenue
-20.6k AUD
Gross Profit
7.1m AUD
Operating Expenses
-23.3m AUD
Operating Income
-16.2m AUD
Other Expenses
-2.5m AUD
Net Income
-18.8m AUD
Fundamental Scores

PAR Profitability Score
Profitability Due Diligence

Paradigm Biopharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
hidden
Profitability
Score

Paradigm Biopharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PAR Solvency Score
Solvency Due Diligence

Paradigm Biopharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Paradigm Biopharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PAR Price Targets Summary
Paradigm Biopharmaceuticals Ltd

Wall Street analysts forecast PAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PAR is 0.66 AUD with a low forecast of 0.66 AUD and a high forecast of 0.68 AUD.

Lowest
Price Target
0.66 AUD
105% Upside
Average
Price Target
0.66 AUD
107% Upside
Highest
Price Target
0.68 AUD
113% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Paradigm Biopharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PAR is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PAR stock?

The intrinsic value of one PAR stock under the Base Case scenario is hidden AUD.

Is PAR stock undervalued or overvalued?

Compared to the current market price of 0.32 AUD, Paradigm Biopharmaceuticals Ltd is hidden .

Back to Top